Infections in patients with multiple sclerosis: A national cohort study in Sweden

Anna Castelo-Branco1, Flaminia Chiesa1, Simona Conte1

  • 1Real-world Insights, IQVIA Nordics, Pyramidvägen 7, 169 56 Solna, Sweden.

Abstract

Insights

Multiple sclerosis patients face a higher risk of serious and non-serious infections, particularly urinary tract and kidney infections, soon after diagnosis. This highlights the need for careful treatment decisions.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is associated with an increased risk of infections.
  • Population-based data on infections in the period immediately following MS diagnosis are limited.

Purpose of the Study:

  • To investigate the incidence of infections in individuals with MS.
  • To stratify infection risk by age and sex in the MS population.

Main Methods:

  • A Swedish population-based cohort study included 6602 incident MS patients and 61,828 matched MS-free controls.
  • Data were collected from national registers between January 2008 and December 2016.
  • Incidence rates (IR) and incidence rate ratios (IRR) were calculated.

Main Results:

  • MS patients had significantly higher IRRs for serious infections (2.54) and non-serious infections (1.61) compared to controls.
  • Elevated risks were observed for skin, respiratory, pneumonia/influenza, bacterial, viral, and fungal infections.
  • Urinary tract/kidney infections showed the highest IRR in MS patients (2.44).
  • Cumulative incidence of most infections was higher in MS patients up to 9 years post-diagnosis.

Conclusions:

  • A substantial burden of infections exists around the time of MS diagnosis.
  • Increased infection risk post-diagnosis warrants careful consideration of treatment risks and benefits, especially concerning disease-modifying therapies.